Why Agenus Stock Is Slumping This Week
Shares of the clinical-stage immunotherapy company Agenus (NASDAQ: AGEN) fell by 11.7% during the first three and half days of trading this week, according to data provided by S&P Global Market Intell...
1.49 | |
1.46 | |
- | |
1.52 | |
1.44 | |
1.25-3.37 | |
495 M | |
333 M | |
98 024 K | |
-0.24 | |
0 | |
1.4918 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Shares of the clinical-stage immunotherapy company Agenus (NASDAQ: AGEN) fell by 11.7% during the first three and half days of trading this week, according to data provided by S&P Global Market Intell...
Agenus Inc. (NASDAQ:AGEN) Q4 2022 Earnings Call Transcript March 14, 2023 Operator: Thank you for holding and welcome, everyone, to the Agenus Fourth Quarter and Full Year 2022 Financial Results Conf...